Back
Coya Therapeutics 10K Form
Sell
30
COYA
Coya Therapeutics
Last Price:
5.85
Seasonality Move:
40.23%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive COYA News And Ratings
See the #1 stock for the next 7 days that we like better than COYA
COYA Financial Statistics
Sales & Book Value
Annual Sales: | $6M |
---|---|
Cash Flow: | $-5.46M |
Price / Cash Flow: | 0 |
Annual Sales: | $2.10 |
Price / Book: | 3.07 |
Profitability
EPS (TTM): | -0.65000 |
---|---|
Net Income (TTM): | $-10.7M |
Gross Margin: | -- |
Return on Equity: | 0% |
Return on Assets: | 0% |
Coya Therapeutics Earnings Forecast
Key Coya Therapeutics Financial Ratios
- The Research & Development expenses have been 100.71% of Revenue.
- The Interest Expense is 0.00% of Operating Income.
- Per Share Earnings over the last 3 years have been positive in 1 years.
Coya Therapeutics Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Biotechnology |
Sector: | Health Care |
Current Symbol: | COYA |
Website: | coyatherapeutics.com |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 0 |
Quick Ratio: | 0 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |
COYA Technical Analysis vs Fundamental Analysis
Sell
30
Coya Therapeutics (COYA)
is a Sell
Is Coya Therapeutics a Buy or a Sell?
-
Coya Therapeutics stock is rated a Sell
The current Coya Therapeutics [COYA] share price is $5.89. The Score for COYA is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.